PharmaResearch (214450) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, PharmaResearch (214450) reported revenue of 536.3 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025536.3 billion KRW214.4 billion KRW168.3 billion KRW[source]
2024350.1 billion KRW126.1 billion KRW88.9 billion KRW[source]
2023261.0 billion KRW92.3 billion KRW77.3 billion KRW[source]
2022194.8 billion KRW65.9 billion KRW43.4 billion KRW[source]
2021154.1 billion KRW52.5 billion KRW46.8 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025989.6 billion KRW290.1 billion KRW699.5 billion KRW[source]
2024799.8 billion KRW259.1 billion KRW540.6 billion KRW[source]
2023498.7 billion KRW63.5 billion KRW435.2 billion KRW[source]
2022438.1 billion KRW92.2 billion KRW345.9 billion KRW[source]
2021393.6 billion KRW83.6 billion KRW310.0 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice